These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10454500)

  • 1. Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice.
    Akamatsu K; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1242-9. PubMed ID: 10454500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological activity of a novel water-soluble hepatocyte-specific polymeric prodrug of prostaglandin E(1) using lactosylated poly(L-glutamic hydrazide) as a carrier.
    Akamatsu K; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    Biochem Pharmacol; 2001 Dec; 62(11):1531-6. PubMed ID: 11728389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targeting.
    Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Takakura Y
    J Control Release; 1999 Nov; 62(1-2):253-62. PubMed ID: 10518658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of polymeric prodrugs of PGE1 for cell-specific hepatic targeting.
    Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Yoshikawa H; Takakura Y
    Pharmazie; 2000 Mar; 55(3):202-5. PubMed ID: 10756541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.
    Hirabayashi H; Nishikawa M; Takakura Y; Hashida M
    Pharm Res; 1996 Jun; 13(6):880-4. PubMed ID: 8792426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
    Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of prostaglandin E1 to hepatocytes using galactosylated liposomes.
    Kawakami S; Munakata C; Fumoto S; Yamashita F; Hashida M
    J Drug Target; 2000; 8(3):137-42. PubMed ID: 10938523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhetic acid-loaded microparticles: liver-specific delivery and therapeutic potential against carbon tetrachloride-induced hepatitis.
    Takahashi H; Onishi H; Machida Y
    J Pharm Pharmacol; 2004 Apr; 56(4):437-44. PubMed ID: 15099438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C; Kawakami S; Yamashita F; Hashida M
    J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor.
    Li C; Newman RA; Wu QP; Ke S; Chen W; Hutto T; Kan Z; Brannan MD; Charnsangavej C; Wallace S
    Cancer Chemother Pharmacol; 2000; 46(5):416-22. PubMed ID: 11127947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved plasma stability and sustained release profile of gemcitabine via polypeptide conjugation.
    Kiew LV; Cheong SK; Sidik K; Chung LY
    Int J Pharm; 2010 May; 391(1-2):212-20. PubMed ID: 20214970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
    Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance associated protein 2 mediates transport of prostaglandin E2.
    de Waart DR; Paulusma CC; Kunne C; Oude Elferink RP
    Liver Int; 2006 Apr; 26(3):362-8. PubMed ID: 16584400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
    Ishida E; Managit C; Kawakami S; Nishikawa M; Yamashita F; Hashida M
    Pharm Res; 2004 Jun; 21(6):932-9. PubMed ID: 15212156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carbon tetrachloride intoxication and ethanol ingestion on interferon production in mice.
    Daniluk J; Chibowski D; Szuster-Ciesielska A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):325-30. PubMed ID: 7487375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties.
    Nishikawa M; Takemura S; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):408-15. PubMed ID: 9765363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E(2) (EP(1)) receptor agonist-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: the involvement of TGF-alpha.
    Kimura M; Osumi S; Ogihara M
    Endocrinology; 2001 Oct; 142(10):4428-40. PubMed ID: 11564707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis.
    Jiang N; Zhang X; Zheng X; Chen D; Siu K; Wang H; Ichim TE; Quan D; McAlister V; Chen G; Min WP
    PLoS One; 2012; 7(9):e44138. PubMed ID: 22970170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety.
    Jeong YI; Seo SJ; Park IK; Lee HC; Kang IC; Akaike T; Cho CS
    Int J Pharm; 2005 May; 296(1-2):151-61. PubMed ID: 15885467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and biological activity of poly (gamma-glutamic acid) -cisplatin conjugate].
    Jin L; Ye HF; Huang J; Jiang L; Hu RZ; Wu ZR
    Yao Xue Xue Bao; 2007 Jun; 42(6):611-7. PubMed ID: 17702397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.